Guideline-directed medical therapy and dose titration are essential to improving outcomes in heart failure with reduced or mildly reduced ejection fraction.According to the CDC, 6.7 million U.S.

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

Novo Nordisk’s post-trial sell-off may be overdone. Click here for this comparative analysis of NVO and LLY stocks and see ...

Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 1:20 PM ESTCompany ParticipantsTom Frohlich ...

CEO Mario Alberto Accardi told attendees at Guggenheim’s 2026 Emerging Outlook Biotech Summit that 2026 is “shaping up to be ...

Full year 2025 ORLADEYO® net revenue of $601.8 million (+38% y-o-y; +43% y-o-y excluding European ORLADEYO revenue following the sale of the ...

FDA Approval for Pediatric Indication -- LINZESS received U.S. FDA approval in November 2025 for IBS-C patients aged 7-17, ...

Phase 1b expansion cohort data evaluating 2000mg of ficerafusp alfa every other week in combination with pembrolizumab in 1L HPV-negative R/M ...

The issues discussed at GWMS were on hydrogen sulfide emissions, refractory nitrogen transformations, fragmented operational ...

The Pulse team looks at the changes to the GP contract for the next financial year and what it will all mean for practices.

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and twelve months ended ...

The trust we place in medical professionals is profound, built on the assumption of care, competence, and an unwavering commitment to our well-being. When that trust is broken, the fallout extends far ...